Canada · Series E startup

Who invested in Neuromed Pharmaceuticals

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$85Mraised across 2 rounds since 2003, from 2 sources

$32MSeries C$53MSeries E
Latest round
Series E, $53MAug 2007
Step-upi
1.7×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2004200520062007
$32MSeries C$53MSeries E
First round
Series C, $32M
Nov 2003
Biggest round
$53M
Series E · Aug 2007
Between rounds
3.8 years
from the last two

The rounds

  1. Aug 2007
    Series E$53M1 new4 returning

    From a historical funding record

  2. Nov 2003

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredZalicusundisclosedDec 2009

From historical deal records. Wrong? Tell us.

Everyone who backed them

BDC CapitalVC firm2rounds
MPM CapitalPrivate equity2rounds
GrowthWorksVC firm2rounds
Royal Bank of CanadaGrowth equity2rounds
MDS CapitalGrowth equity1round
Cogene VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuromed Pharmaceuticals

Who invested in Neuromed Pharmaceuticals?

Neuromed Pharmaceuticals's investors include BDC Capital, MPM Capital, GrowthWorks, Royal Bank of Canada and MDS Capital, and 2 more on record.

How much has Neuromed Pharmaceuticals raised?

Neuromed Pharmaceuticals has raised $85M across 2 rounds since 2003.

When did Neuromed Pharmaceuticals last raise?

Neuromed Pharmaceuticals's most recent round was a Series E of $53M in Aug 2007.

What was Neuromed Pharmaceuticals's biggest round?

Its most recent round, $53M in Aug 2007, is also its largest on record.

Who backed Neuromed Pharmaceuticals first?

Neuromed Pharmaceuticals's first round on record, in Nov 2003, was backed by BDC Capital, MPM Capital and GrowthWorks and 3 others.

What stage is Neuromed Pharmaceuticals at?

Neuromed Pharmaceuticals's latest named round is a Series E, in Aug 2007.

Where is Neuromed Pharmaceuticals based?

Neuromed Pharmaceuticals is based in Canada.

Companies like Neuromed Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.